E E Harris|J Hey - JoVE Visualize

Showing results (91-100 of 121) with videos related to

Pageof 13

Sort By:

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1982

Phosphorus-containing inhibitors of angiotensin-converting enzymeE D Thorsett, E E Harris, E R Peterson, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptorR Aslanian, J E Brown, N Y Shih, et al.

Journal of Medicinal Chemistry|July 1, 1977

Anticoccidial 1-substituted 4(1H)-pyridinone hydrazonesA W Douglas, M H Fisher, J J Fishinger, et al.

The Journal of General Virology|June 18, 2014

Characterization of Barmah Forest virus pathogenesis in a mouse modelLara J Herrero, Brett A Lidbury, Jayaram Bettadapura, et al.

FEBS Letters|June 7, 1993

Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cellsG McAllister, M R Knowles, S Patel, et al.

Human Reproduction (Oxford, England)|December 14, 2020

Comprehensive analysis utilizing flow cytometry and immunohistochemistry reveals inflammatory changes in local endometrial and systemic dendritic cell populations in endometriosisA J Hey-Cunningham, C Wong, J Hsu, et al.

Frontiers in Cellular Neuroscience|May 8, 2025

O 6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatmentMüge Sak, Brian J Williams, Andrew J Hey, et al.

Frontiers in Cellular Neuroscience|July 9, 2025

Corrigendum: O 6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatmentMüge Sak, Brian J Williams, Andrew J Hey, et al.

AIDS (London, England)|March 3, 2015

Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levelsWilliam J Hey-Cunningham, John M Murray, Ven Natarajan, et al.

Biochemistry|November 30, 2006

Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modelingSookhee N Ha, Pat J Hey, Rick W Ransom, et al.

Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:

Pageof 13

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1982

Phosphorus-containing inhibitors of angiotensin-converting enzymeE D Thorsett, E E Harris, E R Peterson, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptorR Aslanian, J E Brown, N Y Shih, et al.

Journal of Medicinal Chemistry|July 1, 1977

Anticoccidial 1-substituted 4(1H)-pyridinone hydrazonesA W Douglas, M H Fisher, J J Fishinger, et al.

The Journal of General Virology|June 18, 2014

Characterization of Barmah Forest virus pathogenesis in a mouse modelLara J Herrero, Brett A Lidbury, Jayaram Bettadapura, et al.

FEBS Letters|June 7, 1993

Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cellsG McAllister, M R Knowles, S Patel, et al.

Human Reproduction (Oxford, England)|December 14, 2020

Comprehensive analysis utilizing flow cytometry and immunohistochemistry reveals inflammatory changes in local endometrial and systemic dendritic cell populations in endometriosisA J Hey-Cunningham, C Wong, J Hsu, et al.

Frontiers in Cellular Neuroscience|May 8, 2025

O 6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatmentMüge Sak, Brian J Williams, Andrew J Hey, et al.

Frontiers in Cellular Neuroscience|July 9, 2025

Corrigendum: O 6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatmentMüge Sak, Brian J Williams, Andrew J Hey, et al.

AIDS (London, England)|March 3, 2015

Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levelsWilliam J Hey-Cunningham, John M Murray, Ven Natarajan, et al.

Biochemistry|November 30, 2006

Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modelingSookhee N Ha, Pat J Hey, Rick W Ransom, et al.

Pageof 13